Evidence map›Paper›PMID 39717960›Full record

Trial reportMedical decision making : an international journal of the Society for Medical Decision Making2025

Testing an HPV Vaccine Decision Aid for 27- to 45-Year-Old Adults in the United States: A Randomized Trial.

Erika L Thompson, Justin Luningham, Sarah A Alkhatib, Jessica Grace, Idara N Akpan, Ellen M Daley, Gregory D Zimet, Christopher W Wheldon

Abstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Medical decision making : an international journal of the Society for Medical Decision Making, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Erika L ThompsonDepartment of Quantitative and Qualitative Health Sciences, University of Texas School of Public Health San Antonio, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.ORCID 0000-0002-7115-0001
Justin LuninghamDepartment of Population and Community Health, College of Public Health, University of North Texas Health Science Center, Fort Worth, TX, USA.
Sarah A AlkhatibDepartment of Population and Community Health, College of Public Health, University of North Texas Health Science Center, Fort Worth, TX, USA.
Jessica GraceDepartment of Population and Community Health, College of Public Health, University of North Texas Health Science Center, Fort Worth, TX, USA.
Idara N AkpanDepartment of Population and Community Health, College of Public Health, University of North Texas Health Science Center, Fort Worth, TX, USA.
Ellen M DaleyCollege of Public Health, University of South Florida, Tampa, FL, USA.
Gregory D ZimetDepartment of Pediatrics, Indiana University School of Medicine and Zimet Research Consulting LLC, Indianapolis, IN, USA.
Christopher W WheldonDepartment of Social & Behavioral Sciences, College of Public Health, Temple University, Philadelphia, PA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn the United States, human papillomavirus (HPV) vaccination among 27- to 45-y-olds (mid-adults) is recommended based on shared clinical decision making with a health care provider. We developed a patient decision aid tool to support the implementation of this mid-adult HPV vaccination guideline. The purpose of this study was to evaluate the effect of a patient decision aid tool for HPV vaccination, HPV DECIDE, compared with an information fact sheet among mid-adults who have not received the HPV vaccine.

methodParticipants were recruited between December 2023 and January 2024. We used a randomized Solomon, 4-group, pretest/posttest design with mid-adults aged 27 to 45 y who were unvaccinated for HPV and balanced based on sex (

resultsParticipants in the intervention group had significantly lower total decisional conflict scores (B = -3.58,

conclusionsThe HPV DECIDE tool for mid-adult HPV vaccination shows promise for immediate reductions in decisional conflict and improvement in knowledge, intentions, and self-efficacy about the HPV vaccine. Future studies are warranted to evaluate the effectiveness of this patient decision aid tool in real-world settings. HIGHLIGHTS: Shared clinical decision making is recommended for HPV vaccination with mid-adults.A patient decision aid for HPV vaccination reduced decisional conflict for mid-adults.The HPV vaccine patient decision aid was acceptable to mid-adults.

Indexed as

Decision Support TechniquesPapillomavirus InfectionsPapillomavirus VaccinesAdultDecision MakingFemaleHealth Knowledge, Attitudes, PracticeHumansMaleMiddle AgedSelf EfficacyUnited StatesVaccinationPapillomavirus Vaccinesadultsdecision aiddecision makingHPV vaccine

Identifiers

PMID39717960
PMCPMC11736972

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.